PD-Rx Pharmaceuticals, Inc. (PDRX)

OTCMKTS · Delayed Price · Currency is USD

3.100

-0.250 (-7.46%)

At close: Aug 27, 2026

Market Cap	5.10M +10.7%
Revenue (ttm)	18.35M -15.1%
Net Income	-257.52K
EPS	-0.16
Shares Out	1.64M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	630
Open	3.100
Previous Close	3.350
Day's Range	3.100 - 3.100
52-Week Range	2.750 - 3.350
Beta	1,546,890.76
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 15, 2026

About PD-Rx Pharmaceuticals

PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company offers prepackaged medications, such as creams, ointments, ophthalmics, otics, liquids, and suspension products. It also provides packaging services. In addition, the company offers a dispensing platform, a manual dispensing system that provides 10 recordkeeping labels to match the 10 bottle trays as a handling package; and PD-Rx Net, a web-based application designed to trac... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 1986

Employees 28

Stock Exchange OTCMKTS

Ticker Symbol PDRX

Full Company Profile

Financial Performance

In fiscal year 2025, PD-Rx Pharmaceuticals's revenue was $18.35 million, a decrease of -3.15% compared to the previous year's $18.95 million. Losses were -$257,523, -65.82% less than in 2024.

Financial Statements